Institutional members access full text with Ovid®

Share this article on:

Insulin-like Growth Factor-I Liposomal Gene Transfer and Systemic Growth Hormone Stimulate Wound Healing

Pierre E. J. MD; Perez-Polo, J. Regino PhD; Mitchell, Alfred T. MD; Matin, Sina MD; Foyt, Howard L. MD, PhD; Herndon, David N. MD
Journal of Burn Care & Research: July-August 1997

Many of the anabolic effects of growth hormone (GH) act through insulin-like growth factor-I (IGF-I). Systemic administration of GH in combination with IGF-I has been shown to stimulate wound reepithelialization, however, it causes hyperglyccmia or hypoglycemia, respectively. We hypothesize that very low doses of IGF-I in a liposome form will have the same positive wound-healing effect when administered locally as the higher doses of GH plus IGF-I given systemically. To test this hypothesis, rats were given a 40% TBSA full-thickness scald injury and received either placebo IGF-I (5.0 mg/kg/day, subcutaneously), IGF-I liposome (0.9 μ/kg/week, subcutancously), or a combination of GH and IGF-I, or IGF-I liposomes for 8 wccks. GH in combination with IGF-I showed a significant increase in postburn weight. Wound reepithelialization, measured by computerized planimetry as percentage original wound area, was significantly increased in rats receiving GH plus IGF-I, GH plus IGF-I liposomes, and IGF-I liposomes when compared to sham, or IGF-I (p < 0.05). Results indicate that small doses of IGF-I, delivered in the form of liposomes, are equally effective in increasing burn wound rcepithelialization as the higher doses of GH plus IGF-I, or GH plus IGF-I liposomes.

©1997The American Burn Association